Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism

Inhibitors of the mammalian target of rapamycin (mTOR) have improved the treatment of renal cell carcinoma (RCC). However, chronic drug exposure may trigger resistance, limiting the utility of these agents. The metastatic behavior of RCC cells, susceptible (RCCpar) or resistant (RCCres) to the mTOR...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Eva Juengel, Jasmina Makarević, Michael Reiter, Jens Mani, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A. Blaheta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2014-04-01
Sarja:Neoplasia: An International Journal for Oncology Research
Linkit:http://www.sciencedirect.com/science/article/pii/S147655861400030X
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia